✦ LIBER ✦

Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial

✍ Scribed by Andrew IR Maas; Gordon Murray; Herbert Henney III; Nadim Kassem; Valerie Legrand; Miriam Mangelus; Jan-Paul Muizelaar; Nino Stocchetti; Nachshon Knoller

Book ID: 114408186
Publisher: The Lancet
Year: 2006
Tongue: English
Weight: 111 KB
Volume: 5
Category: Article
ISSN: 1474-4465
DOI: 10.1016/s1474-4422(05)70253-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Golimumab in psoriatic arthritis: One-ye

Golimumab in psoriatic arthritis: One-year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo-controlled trial

✍ Arthur Kavanaugh; Désirée van der Heijde; Iain B. McInnes; Philip Mease; Gerald 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB

61 Tiotropium Respimat in cystic fibrosi

61 Tiotropium Respimat in cystic fibrosis: Efficacy and safety results of phase III randomized placebo-controlled trial

✍ Ratjen, F.; Koker, P.; Geller, D.; Langellier-Cocteaux, B.; Maulf, F. Le; Katten 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Comparison of hypothermia and normotherm

Comparison of hypothermia and normothermia after severe traumatic brain injury in children (Cool Kids): a phase 3, randomised controlled trial

✍ Adelson, P David; Wisniewski, Stephen R; Beca, John; Brown, S Danielle; Bell, Mi 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 313 KB

Efficacy and safety of golimumab in pati

Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double-blind, placebo-controlled, phase III trial

✍ Robert D. Inman; John C. Davis Jr.; Désirée Van Der Heijde; Laura Diekman; Joach 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 2 views

## Abstract ## Objective To evaluate the efficacy and safety of golimumab in patients with ankylosing spondylitis (AS) in the GO‐RAISE study. ## Methods Patients with active AS, a Bath AS Disease Activity Index (BASDAI) score ≥4, and a back pain score of ≥4 were randomly assigned in a 1.8:1.8:1

Efficacy and safety results from a phase

Efficacy and safety results from a phase III, randomized controlled trial comparing the safety and efficacy of briakinumab with etanercept and placebo in patients with moderate to severe chronic plaque psoriasis

✍ B.E. Strober; J.J. Crowley; P.S. Yamauchi; M. Olds; D.A. Williams 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 293 KB

Efficacy and safety of belimumab in pati

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

✍ Sandra V Navarra; Renato M Guzmán; Alberto E Gallacher; Stephen Hall; Roger A Le 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 239 KB